Canlyniadau Chwilio - Caroline Robert
- Dangos 1 - 20 canlyniadau o 201
- Ewch i'r Dudalen Nesaf
-
1
A decade of immune-checkpoint inhibitors in cancer therapy gan Caroline Robert
Cyhoeddwyd 2020Artigo -
2
-
3
Persistent Cancer Cells: The Deadly Survivors gan Shensi Shen, Stéphan Vagner, Caroline Robert
Cyhoeddwyd 2020Revisão -
4
-
5
The new era of adjuvant therapies for melanoma gan Alexander M.M. Eggermont, Caroline Robert, Antoni Ribas
Cyhoeddwyd 2018Revisão -
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
CTLA-4 Blockade Confers Lymphocyte Resistance to Regulatory T-Cells in Advanced Melanoma: Surrogate Marker of Efficacy of Tremelimumab? gan Cédric Menard, François Ghiringhelli, S. Roux, Nathalie Chaput, Christine Mateus, Ursula Grohmann, Sophie Caillat‐Zucman, Laurence Zitvogel, Caroline Robert
Cyhoeddwyd 2008Artigo -
16
-
17
Melanoma-associated fibroblasts decrease tumor cell susceptibility to NK cell-mediated killing through matrix-metalloproteinases secretion gan Linda Ziani, Thouraya Ben Safta-Saadoun, Johanne Gourbeix, Andréa Cavalcanti, Caroline Robert, Gilles Favre, Salem Chouaı̈b, Jérôme Thiery
Cyhoeddwyd 2017Artigo -
18
-
19
Corrections to “Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up gan J.B.A.G. Haanen, Franck Carbonnel, Caroline Robert, K.M. Kerr, Solange Peters, James Larkin, Karin Jordan
Cyhoeddwyd 2018Errata/Corrigenda -
20
Offerynnau Chwilio:
Pynciau Perthynol
Medicine
Internal medicine
Cancer research
Cancer
Oncology
Melanoma
Immunotherapy
Biology
Metastatic melanoma
Ipilimumab
Immunology
Adverse effect
Clinical trial
Pembrolizumab
Vemurafenib
Chemotherapy
Pathology
Surgery
Immune system
Cell biology
Confidence interval
Biochemistry
Gastroenterology
Hazard ratio
MAPK/ERK pathway
Genetics
Randomized controlled trial
Clinical endpoint
Gene
Kinase